Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole

AIM: This study tested for associations between SLCO1B1 polymorphisms and circulating estrogen levels in women with breast cancer treated with letrozole or exemestane. PATIENTS & METHODS: Postmenopausal women with hormone-receptor positive breast cancer were genotyped for SLCO1B1*5 (rs4149056) a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharmacogenomics
Asıl Yazarlar: Dempsey, Jacqueline M, Kidwell, Kelley M, Gersch, Christina L, Pesch, Andrea M, Desta, Zeruesenay, Storniolo, Anna Maria, Stearns, Vered, Skaar, Todd C, Hayes, Daniel F, Henry, N Lynn, Rae, James M, Hertz, Daniel L
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Future Medicine Ltd 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6891932/
https://ncbi.nlm.nih.gov/pubmed/31190621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2019-0020
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller